Can an inhibitor of a multidrug pump become a substrate?

Hutchison, Ella (2022) Can an inhibitor of a multidrug pump become a substrate? MRes thesis, University of Nottingham.

[thumbnail of Ella Hutchison MRes thesis - 20214453 final submission.pdf]
Preview
PDF (Thesis - as examined) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution.
Download (3MB) | Preview

Abstract

ABCG2 is an ATP binding cassette (ABC) transporter that is involved in multidrug resistance, particularly anti-cancer drugs such as methotrexate and mitoxantrone. Distinguishing between substrates and inhibitors is important for rational design of drugs that won’t be transported by ABCG2 and inhibitors that prevent transport of existing ABCG2 substrates. In this project, the hypothesis being proposed is that ligands with a higher affinity for ABCG2 act as inhibitors and the transient conformational changes required for transport do not occur. Whereas transported substrates have a lower affinity for ABCG2 and the conformational changes can occur. Therefore, if the affinity for a widely used inhibitor, Ko143, was reduced, would it become a substrate that is transported by ABCG2? A series of mutants (T435A, N436A, F439A, S440W, M549E, A397S/V401A/L539A and L405A/I543A/V546A) were designed using cryo-EM structures of ABCG2 bound to MZ29 (a Ko143 analogue) and mutational studies of substrate transport. The aim was to reduce affinity of ABCG2 for Ko143. All mutant proteins, except M549E, were successfully expressed in HEK293T cells and trafficked to the cell membrane. Using flow cytometry, cellular accumulation of fluorescent Ko143 derivatives (Ko143-Cy5 and Ko143-X-BY630) was measured which indicates whether they are exported by ABCG2 or not. Ko143-Cy5 fluorescence was significantly higher in WT-ABCG2 expressing cells compared with the untransfected control and the other ABCG2 mutants, except for A397S/V401A/L539A. Ko143-X-BY630 showed a similar pattern but without significance. The reduction in cellular accumulation of the fluorescent Ko143 derivatives in the mutants could be caused by the reduced affinity leading to ABCG2-mediated transport or increased diffusion out of the cell. Transport of Ko143-Cy5 or Ko143-X-BY630 cannot be ruled out but it is not detectable in this experiment. Consideration of the data in this thesis alongside emerging structural and functional data from other laboratories will continue to shed light on the interaction of substrates and inhibitors with ABCG2.

Item Type: Thesis (University of Nottingham only) (MRes)
Supervisors: Kerr, Ian
Keywords: Multidrug resistance, Inhibitor, Substrate
Subjects: Q Science > QP Physiology > QP501 Animal biochemistry
Faculties/Schools: UK Campuses > Faculty of Medicine and Health Sciences > School of Life Sciences
Item ID: 67260
Depositing User: Hutchison, Ella
Date Deposited: 31 Jul 2022 04:40
Last Modified: 31 Jul 2022 04:40
URI: https://eprints.nottingham.ac.uk/id/eprint/67260

Actions (Archive Staff Only)

Edit View Edit View